Search Within

Guido Dalbagni

  1. "Genitourinary Oncology Service"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (45)
  3. Correspondence (4)
  4. Review (2)
  5. Book Section (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (102)
  2. Genitourinary Oncology Service (102)
  3. Solid Tumor Oncology Division (102)
  4. Surgery (102)
  5. Urology (102)
  6. Department of Pathology and Laboratory Medicine (75)

More Groups

People
  1. Bernard Bochner (82)
  2. Dean Bajorin (80)
  3. Hikmat Al-Ahmadie (64)
  4. Gopakumar Iyer (62)
  5. Jonathan Rosenberg (62)
  6. David Solit (51)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (6)
  5. 2021 (8)
  6. 2020 (11)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Modern Pathology (10)
  3. Journal of Urology (9)
  4. Laboratory Investigation (9)
  5. Cancer (4)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. Elsevier Science, Inc. (14)
  3. Nature Publishing Group (11)
  4. Elsevier Inc. (10)
  5. Nature Research (10)
  6. American Association for Cancer Research (8)

More Publishers

Results (102)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of routine preoperative (18)F-fluorodeoxyglucose positron emission tomography/computerized tomography in identifying pathological lymph node metastases at radical cystectomy
    Journal Article

    Dason, S.; Wong, N. C.; Donahue, T. F.; Meier, A.; Zheng, J.; Mannelli, L.; Di Paolo, P. L.; Dean, L. W.; McPherson, V. A.; Rosenberg, J. E.; more...
    Journal of Urology (2020)

    Fulltext@MSK | Save
  • Next-generation sequencing of Bacille Calmette-Guerin (BCG)-unresponsive tumors identifies actionable alterations for potential targeted therapy in non-muscle invasive bladder cancer
    Meeting Abstract

    Walasek, A.; Almassi, N.; McPherson, V.; Dason, S.; Benfante, N.; Klein, T.; Berger, M. F.; Schultz, N.; Dalbagni, G.; Bajorin, D. F.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Characterization of tumor mutational landscape in smokers and nonsmokers with urothelial carcinoma
    Meeting Abstract

    Walasek, A.; Almassi, N.; Teo, M. Y.; Funt, S.; Schultz, N.; Dalbagni, G.; Hu, W.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Reply by authors
    Correspondence

    Dason, S.; Wong, N. C.; Donahue, T. F.; Meier, A.; Zheng, J.; Mannelli, L.; Di Paolo, P. L.; Dean, L. W.; McPherson, V. A.; Rosenberg, J. E.; more...
    Journal of Urology (2020)

    Fulltext@MSK | Save
  • Genomic determinants of nested variant urothelial carcinoma
    Meeting Abstract

    Clinton, T. N.; Whiting, K.; Silva, V.; Li, Q.; Almassi, N.; Pietzak, E.; Bagrodia, A.; Cha, E. K.; Dalbagni, G.; Iyer, G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Marker lesion study of oral FGFR inhibitor BGJ398 in patients with FGFR3-altered intermediate-risk nonmuscle-invasive bladder cancer
    Meeting Abstract

    Cha, E. K.; Iyer, G.; Funt, S. A.; Regazzi, A. M.; Francis, J.; Heinemann, M. H.; Ostrovnaya, I.; Dalbagni, G.; Bajorin, D. F.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Cancer susceptibility mutations in patients with urothelial malignancies
    Journal Article

    Carlo, M. I.; Ravichandran, V.; Srinavasan, P.; Bandlamudi, C.; Kemel, Y.; Ceyhan-Birsoy, O.; Mukherjee, S.; Mandelker, D.; Chaim, J.; Knezevic, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy
    Journal Article

    Feuerstein, M. A.; Goldstein, L.; Reaves, B.; Sun, A.; Goltzman, M.; Morganstern, B. A.; Shabsigh, A.; Bajorin, D. F.; Rosenberg, J. E.; Donat, S. M.; more...
    World Journal of Urology (2019)

    Fulltext@MSK | Save
  • Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma
    Meeting Abstract

    Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • PD-L1 expression in urothelial carcinoma with predominant or pure variant histology: Concordance among 3 commonly used and commercially available antibodies
    Journal Article

    Reis, H.; Serrette, R.; Posada, J.; Lu, V.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Sirintrapun, S. J.; Iyer, G.; more...
    American Journal of Surgical Pathology (2019)

    Fulltext@MSK | Save